Prepare earlier. Improve continuously.
Practical US FDA inspection readiness support for pharmaceutical manufacturers outside the United States—remote-first, with on-site engagements when needed.
Discuss your facility ↗Turn readiness into everyday practice.
A conventional assessment may identify gaps. Our goal is to help teams close them through practical operational controls, targeted digital workflows and clear ownership.
GMP gap review
Prioritize risks across documentation, production controls, quality oversight, data integrity and training.
Request a discussion →02 / STRENGTHENRemediation support
Translate findings into practical action plans, evidence requirements and sustainable process improvements.
Request a discussion →03 / SUSTAINDigital prevention
Explore targeted verification, monitoring and review workflows that help sustain improvements between inspections.
Request a discussion →Remote when practical. On-site when valuable.
Scope depends on the facility, access to evidence and risk. Qualified site personnel retain responsibility for GMP decisions, validation and inspection outcomes.